@atsblueeditor.bsky.social
Posting content from the American Journal of Respiratory and Critical Care Medicine; follows do not indicate endorsement. #pulmCC #sleepmed #AJRCCM #RespEd #ATS #medsky https://www.atsjournals.org/journal/ajrccm
Sarcoidosis Resolvers and Progressors Demonstrate Distinct Systemic Metabolomic Profiles
In subjects with sarcoidosis, the authors identified distinct serum metabolomic profiles present at the time of diagnosis that corresponded to clinical outcomes
#medsky
🔗 tinyurl.com/5xmbbas2
📰 AJRCCM IN THE NEWS
See research from AJRCCM highlighted in the New York Times article, "A Coal-Processing Plant Closed. Local E.R. Visits Dropped Sharply."
🔗 tinyurl.com/bdf376ha
Read the paper here: tinyurl.com/3a7yrjyr
@atscommunity.bsky.social #medsky
The Blue Journal thanks Ling Sun, PhD, for his contribution to the October issue
STAT3-Dependent Regulation of CFTR and Ciliogenesis Is Essential for Mucociliary Clearance and Innate Airway Defense in Hyper-IgE Syndrome
www.atsjournals.org/doi/full/10....
Spontaneous Pneumothorax as First Presentation of Pulmonary Alveolar Microlithiasis
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/mwsy6mk8
The Blue Journal thanks Feng Yuan, PhD, for his contribution to the October issue
Ionocyte Cystic Fibrosis Transmembrane Conductance Regulator Coordinates Chloride Absorption and Secretion to Balance Airway Fluid
www.atsjournals.org/doi/full/10....
📣Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in thoracic malignancies
📅Deadline: October 28, 2025
🔬Learn More Here: tinyurl.com/yc3f9r7y
🖱️Submit here: tinyurl.com/3h7dmm2x
@atscommunity.bsky.social
@ats-toa.bsky.social
#medsky
Breaking Barriers: Enhancing Access, Equity, and Efficiency in Interstitial Lung Disease Clinical Trials
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/2my8eskr
What role does AI play in training the next generation of doctors? As Kaele Leonard, MD, Vanderbilt University School of Medicine, explains on this ep of the ATS Breathe Easy podcast, there's still value to learning to do procedures without AI assistance.
Watch now: www.youtube.com/watch?v=VQSh...
The Blue Journal thanks Jonathan Rayment, MDCM, MSc, FRCPC, for his contribution to the October issue
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One F508del Allele
www.atsjournals.org/doi/full/10....
Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis
Standalone lung function decline provides better mortality discrimination and similar net benefit for antifibrotic initiation than PPF guideline criteria
#medsky
🔗 tinyurl.com/msypy54w
Progress in Progressive Pulmonary Fibrosis
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/mnt2ejy8
Thanks to Rachel Linnemann, MD, for her contribution to the October issue
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele
@emory-choa-cfair.bsky.social
www.atsjournals.org/doi/full/10....
A 10,000-Foot View at Survival and Treatment with Phosphodiesterase-5 Inhibitors in Interstitial Lung Disease Pulmonary Hypertension
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/32xvxtpf
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/yeu6f7tv
The Blue Journal thanks Ashwatha Thenappan, MD, for her contribution to the October issue
Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis
www.atsjournals.org/doi/full/10....
Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis
Studying long-term effects of air pollution may guide air quality standards and regulations for vulnerable populations
@pittdeptofmed.bsky.social
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/36xbdkem
Particles Matter: Air Pollution and Disparities in Sarcoidosis
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/yf8fbjpa
🎙️ Just published a new episode of Out of the Blue: An AJRCCM Podcast: Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography and Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis. Have a listen:
09.10.2025 16:02 — 👍 1 🔁 0 💬 0 📌 0
The Blue Journal thanks Athiththan Yogeswaran, MD, for his contribution to the October issue
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in ILD: A PVRI GoDeep Meta-Registry Analysis
www.atsjournals.org/doi/full/10....
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease
PM2.5 and its constituents are associated with differential DNA methylation in the blood of patients with fibrotic ILD
@gilliangoobie.bsky.social #medsky
🔗 tinyurl.com/2rk6wwmn
From Smog to Scar: Epigenetic Signatures of Air Pollution in Interstitial Lung Disease
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/5h9r9jvx
The Blue Journal thanks Sharon E. Kim, BS, for her contribution to the October issue
Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis
@pittdeptofmed.bsky.social
www.atsjournals.org/doi/full/10....
Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/mr25hrvt
To B or Not to B: Germinal Center Responses in Progressive Fibrotic Interstitial Lung Disease
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/9wyd6npe
How can asthma experts best inform their colleagues of the uses of anti-inflammatory therapies? Njira Lugogo, MD, of University of Michigan Health, explains all of the tools she implements on this latest episode of the ATS Breathe Easy podcast.
Watch the episode now: www.youtube.com/watch?v=dXiP...
The Blue Journal thanks Vaibhav Upadhyay, MD, PhD, for his contribution to the October issue
Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease
www.atsjournals.org/doi/full/10....
Associations of High Attenuation Area–Related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities
@jskim8223.bsky.social @atscommunity.bsky.social #medsky
🔗 tinyurl.com/da3jsx8n
Who Will Evolve from Interstitial Lung Abnormalities to Interstitial Lung Disease? Early Radio-Proteomic Warning Signals in the Lung
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/fx4aj5br
The Blue Journal thanks Tania Estefania Velez, PhD, for her contribution to the October issue
Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease
www.atsjournals.org/doi/full/10....
Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography
Patients with a typical fibrotic hypersensitivity pneumonitis (HP) pattern on chest CT frequently have non-HP diagnoses
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/36cnkake
